Trial intelligence / Profile preview

Tolvaptan in Patients With Hyponatremia

NCT00072683Phase 3Completed

Sponsor
Otsuka Pharmaceutical Development & Commercialization
Start
Apr 2003
Primary completion
Dec 2005
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hyponatremia comparing Tolvaptan with Placebo (2 arms). Started Apr 2003; status: completed.

02

Drugs

tolvaptan
03

Conditions

hyponatremia

Beyond the preview

Go deeper on NCT00072683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00072683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call